Biogen pays Ionis $75 million to develop muscle drug after trial success
 

Biogen pays Ionis $75 million to develop muscle drug after trial success
(Reuters) - Biogen Inc said it would exercise an option to develop and commercialize an experimental genetic muscle-disorder drug after an interim analysis of late-stage data showed patients experienced statistically significant improvement in symptoms.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...O8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...O8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/2kAYfFXRxgc